AssetMark Inc’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-15
Closed 1502
2018
Q2
$0 Hold
15
﹤0.01% 1502
2018
Q1
$0 Hold
15
﹤0.01% 2242
2017
Q4
$0 Hold
15
﹤0.01% 2275
2017
Q3
$0 Hold
15
﹤0.01% 1678
2017
Q2
$0 Hold
15
﹤0.01% 1544
2017
Q1
$0 Hold
15
﹤0.01% 1525
2016
Q4
$0 Hold
15
﹤0.01% 1444
2016
Q3
$0 Hold
15
﹤0.01% 1305
2016
Q2
$0 Hold
15
﹤0.01% 1316
2016
Q1
$0 Hold
15
﹤0.01% 1513
2015
Q4
$0 Buy
+15
New +$15 ﹤0.01% 1528
2015
Q1
Sell
-2,050
Closed -$2K 516
2014
Q4
$2K Buy
+2,050
New +$2.22K ﹤0.01% 462

AssetMark Inc's BTX.WS Position: Q3 2018 in Review

AssetMark Inc sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 15 shares.

AssetMark Inc first reported a position in BTX.WS in Q4 2014 and held it in 12 quarters. The position peaked at $2K in Q4 2014. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • AssetMark Inc reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • AssetMark Inc sold 15 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • AssetMark Inc first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 12 quarters.
  • AssetMark Inc's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $2K in Q4 2014.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on AssetMark Inc's 13F filing for Q3 2018, filed 13 Nov 2018.